Suppr超能文献

原位形成制剂:使用 3(3) 析因设计进行开发、评估和优化。

In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design.

机构信息

Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221005, India.

出版信息

AAPS PharmSciTech. 2009;10(3):977-84. doi: 10.1208/s12249-009-9285-3. Epub 2009 Jul 28.

Abstract

The present investigation concerns with the development and optimization of an in situ forming formulation using 3(3) full factorial design experimentation. Metformin, an antidiabetic drug with upper part of gastrointestinal tract as absorption window was used as a model drug. The formulations were designed with an objective to retain in stomach for an extended time period. The effect of three independent factors--concentrations of sodium alginate (X(1)), gellan gum (X(2)), and metformin (X(3)) on in vitro drug release were used to characterize and optimize the formulation. Five dependent variables-release exponent (Y(1)), dissolution efficiency (Y(2)), drug release at 30 min (Y(3)), 210 min (Y(4)), and 480 min (Y(5)) were considered as optimization factors. The data were statistically analyzed using ANOVA, and a p < 0.05 was considered statistically significant. Three dimensional surface response plots were drawn to evaluate the interaction of independent variables on the chosen dependent variables. Of the prepared 27 formulations, the responses exhibited by batch F17 containing medium level sodium alginate (X(1)), low level gellan (X(2)), and medium level metformin (X(3)) were similar to the predicted responses.

摘要

本研究采用 3(3) 全因子设计实验,致力于开发和优化原位形成制剂。二甲双胍是一种具有上胃肠道吸收窗的抗糖尿病药物,被用作模型药物。制剂设计的目的是延长在胃中的停留时间。三个独立因素——海藻酸钠浓度(X(1))、结冷胶浓度(X(2))和二甲双胍浓度(X(3))对体外药物释放的影响,用于对制剂进行特征描述和优化。五个因变量——释放指数(Y(1))、溶解效率(Y(2))、30 分钟时的药物释放(Y(3))、210 分钟时的药物释放(Y(4))和 480 分钟时的药物释放(Y(5))被视为优化因素。数据采用方差分析进行统计学分析,p < 0.05 被认为具有统计学意义。绘制了三维表面响应图,以评估独立变量对所选因变量的相互作用。在所制备的 27 种制剂中,含有中水平海藻酸钠(X(1))、低水平结冷胶(X(2))和中水平二甲双胍(X(3))的批次 F17 的响应与预测响应相似。

相似文献

1
In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design.
AAPS PharmSciTech. 2009;10(3):977-84. doi: 10.1208/s12249-009-9285-3. Epub 2009 Jul 28.
4
Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
Drug Des Devel Ther. 2015 Jun 19;9:3125-39. doi: 10.2147/DDDT.S82935. eCollection 2015.
5
Sodium alginate microspheres of metformin HCl: formulation and in vitro evaluation.
Curr Drug Deliv. 2007 Jul;4(3):249-56. doi: 10.2174/156720107781023875.
10
Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation.
Eur J Pharm Biopharm. 2007 Aug;67(1):196-201. doi: 10.1016/j.ejpb.2006.12.015. Epub 2006 Dec 28.

引用本文的文献

1
The development of an in-situ biopolymer-based floating gel for the oral delivery of metformin hydrochloride.
Heliyon. 2023 Mar 23;9(4):e14796. doi: 10.1016/j.heliyon.2023.e14796. eCollection 2023 Apr.
2
Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery.
Adv Pharm Bull. 2021 Jan;11(1):150-162. doi: 10.34172/apb.2021.016. Epub 2020 Nov 7.
4
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.
Drug Deliv. 2018 Nov;25(1):1161-1174. doi: 10.1080/10717544.2018.1474969.
5
Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.
PLoS One. 2017 Feb 21;12(2):e0172306. doi: 10.1371/journal.pone.0172306. eCollection 2017.
6
Xyloglucan Based In Situ Gel of Lidocaine HCl for the Treatment of Periodontosis.
J Pharm (Cairo). 2016;2016:3054321. doi: 10.1155/2016/3054321. Epub 2016 Jan 28.
7
Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.
Saudi Pharm J. 2015 Oct;23(5):549-55. doi: 10.1016/j.jsps.2015.02.001. Epub 2015 Mar 3.

本文引用的文献

1
Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.
Eur J Pharm Sci. 2006 Oct 1;29(2):139-47. doi: 10.1016/j.ejps.2006.06.007. Epub 2006 Jun 27.
2
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design.
Eur J Pharm Biopharm. 2006 Jan;62(1):77-84. doi: 10.1016/j.ejpb.2005.07.001. Epub 2005 Sep 8.
3
Application of experimental design methodology in development and optimization of drug release method.
Int J Pharm. 2005 Mar 3;291(1-2):39-49. doi: 10.1016/j.ijpharm.2004.07.041. Epub 2005 Jan 12.
5
Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.
Int J Pharm. 2003 Jun 4;258(1-2):55-64. doi: 10.1016/s0378-5173(03)00163-7.
6
Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.
Int J Pharm. 2002 Jun 4;239(1-2):81-91. doi: 10.1016/s0378-5173(02)00054-6.
7
Comparison of in situ gelling formulations for the oral delivery of cimetidine.
Int J Pharm. 2001 Jun 4;220(1-2):161-8. doi: 10.1016/s0378-5173(01)00669-x.
9
Optimisation of floating matrix tablets and evaluation of their gastric residence time.
Int J Pharm. 2000 Feb 15;195(1-2):125-35. doi: 10.1016/s0378-5173(99)00378-6.
10
Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.
Br J Clin Pharmacol. 1996 Oct;42(4):510-2. doi: 10.1111/j.1365-2125.1996.tb00017.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验